Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
JCI Insight|August 24, 2018
Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinomaAnshuman Panda, Aguirre A de Cubas, Mark Stein, et al.
Open Forum Infectious Diseases|January 16, 2025
The Prevalence of Multidrug Resistance in Enterobacterales Is Higher in Patients Undergoing Hematopoietic Stem Cell TransplantationTessa M Andermann, Dylan Brown, Thomas Holowka, et al.
Cancer Immunology Research|September 14, 2019
Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic EpitopesChristof C Smith, Shengjie Chai, Amber R Washington, et al.
Blood|July 11, 2008
TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejectionPatricia A Taylor, Michael J Ehrhardt, Christopher J Lees, et al.
The Journal of Clinical Investigation|November 17, 2007
CD200 is induced by ERK and is a potential therapeutic target in melanomaKimberly B Petermann, Gabriela I Rozenberg, Daniel Zedek, et al.
Journal for Immunotherapy of Cancer|August 1, 2023
Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomasNicholas P Tschernia, Hillary Heiling, Allison M Deal, et al.
Blood|June 27, 2013
CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host diseaseJames M Coghill, Kenneth A Fowler, Michelle L West, et al.
Transplantation and Cellular Therapy|September 2, 2021
Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous LeukemiaNicholas P Tschernia, Vaibhav Kumar, Dominic T Moore, et al.
Blood|September 3, 2010
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13Steven L Highfill, Paulo C Rodriguez, Qing Zhou, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable anti-tumor immunity in triple negative breast cancerAlex J Smith, Zachary Schrank, Nan Guan, et al.
Pageof 13